327 related articles for article (PubMed ID: 29611002)
1. Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma.
Zarrabi K; Wu S
Curr Oncol Rep; 2018 Apr; 20(5):41. PubMed ID: 29611002
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic developments in renal cell cancer.
Prenen H; Gil T; Awada A
Crit Rev Oncol Hematol; 2009 Jan; 69(1):56-63. PubMed ID: 18752971
[TBL] [Abstract][Full Text] [Related]
3. Current and Emerging Treatments for Metastatic Renal Cell Carcinoma.
Cavaliere C; D'Aniello C; Pepa CD; Pisconti S; Berretta M; Facchini G
Curr Cancer Drug Targets; 2018; 18(5):468-479. PubMed ID: 28183256
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint Inhibitors for the Treatment of Renal Cell Carcinoma.
Ghatalia P; Zibelman M; Geynisman DM; Plimack ER
Curr Treat Options Oncol; 2017 Jan; 18(1):7. PubMed ID: 28210995
[TBL] [Abstract][Full Text] [Related]
5. Safety of available treatment options for renal cell carcinoma.
Derosa L; Albiges L; Massard C; Loriot Y; Fizazi K; Escudier B
Expert Opin Drug Saf; 2016 Aug; 15(8):1097-106. PubMed ID: 27142582
[TBL] [Abstract][Full Text] [Related]
6. [Targeted treatment of renal cell carcinoma, treatment caused side-effects and side-effect management].
Nagyiványi K; Géczi L
Orv Hetil; 2017 Sep; 158(38):1488-1502. PubMed ID: 28920717
[TBL] [Abstract][Full Text] [Related]
7. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies.
Thomas JS; Kabbinavar F
Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335
[TBL] [Abstract][Full Text] [Related]
8. Treatment of renal cell carcinoma: Current status and future directions.
Barata PC; Rini BI
CA Cancer J Clin; 2017 Nov; 67(6):507-524. PubMed ID: 28961310
[TBL] [Abstract][Full Text] [Related]
9. Modern Systemic Therapy for Metastatic Renal Cell Carcinoma of the Clear Cell Type.
Parikh M; Lara PN
Annu Rev Med; 2018 Jan; 69():209-221. PubMed ID: 29144835
[TBL] [Abstract][Full Text] [Related]
10. Kidney cancer therapy: new perspectives and avenues.
Alexandrescu DT; Dasanu CA
Expert Opin Pharmacother; 2006 Dec; 7(18):2481-93. PubMed ID: 17150003
[TBL] [Abstract][Full Text] [Related]
11. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
12. Contemporary treatment of metastatic renal cell carcinoma.
Wiechno P; Kucharz J; Sadowska M; Michalski W; Sikora-Kupis B; Jonska-Gmyrek J; Poniatowska G; Nietupski K; Ossolinski K; Demkow T
Med Oncol; 2018 Oct; 35(12):156. PubMed ID: 30368624
[TBL] [Abstract][Full Text] [Related]
13. T-cell checkpoint inhibitors in metastatic renal cell carcinoma.
Grünwald V
Curr Opin Urol; 2015 Sep; 25(5):411-5. PubMed ID: 26125506
[TBL] [Abstract][Full Text] [Related]
14. Current State of Systemic Therapies for Advanced Renal Cell Carcinoma.
Gulati S; Vaishampayan U
Curr Oncol Rep; 2020 Feb; 22(3):26. PubMed ID: 32048058
[TBL] [Abstract][Full Text] [Related]
15. The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma.
Bilen MA; Carlisle JW; Sonpavde G
Expert Opin Investig Drugs; 2018 Feb; 27(2):163-170. PubMed ID: 29323560
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy in renal cell carcinoma.
Massari F; Di Nunno V; Ciccarese C; Graham J; Porta C; Comito F; Cubelli M; Iacovelli R; Heng DYC
Cancer Treat Rev; 2017 Nov; 60():152-157. PubMed ID: 28992528
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma: recent advances and current therapeutic options.
Schrader AJ; Hofmann R
Anticancer Drugs; 2008 Mar; 19(3):235-45. PubMed ID: 18510169
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant Therapy for High Risk Localized Kidney Cancer: Emerging Evidence and Future Clinical Trials.
Lenis AT; Donin NM; Johnson DC; Faiena I; Salmasi A; Drakaki A; Belldegrun A; Pantuck A; Chamie K
J Urol; 2018 Jan; 199(1):43-52. PubMed ID: 28479237
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy of metastatic renal cell carcinoma: Review of the current literature.
Zerdes I; Tolia M; Tsoukalas N; Mitsis M; Kardamakis D; Pistevou-Gombaki K; Tsekeris P; Kyrgias G
Urologia; 2019 Feb; 86(1):3-8. PubMed ID: 30270773
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies: another option for metastatic RCC.
Hutchinson L
Nat Rev Clin Oncol; 2013 Nov; 10(11):607. PubMed ID: 24061041
[No Abstract] [Full Text] [Related]
[Next] [New Search]